OPKO Health Inc
F:XCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OPKO Health Inc
F:XCY
|
US |
|
UTZ Brands Inc
NYSE:UTZ
|
US |
|
Anglo American PLC
F:NGLD
|
UK |
|
G
|
Goldman Sachs Group Inc
SWB:GOS
|
US |
|
T
|
T-Mobile US Inc
F:TM5
|
US |
|
A
|
Amarin Corporation PLC
F:EH3A
|
IE |
|
Oxford Instruments PLC
F:OX3
|
UK |
|
Lee Enterprises Inc
NASDAQ:LEE
|
US |
|
N
|
Nice Ltd
TASE:NICE
|
IL |
|
M
|
Monster Beverage Corp
F:MOB
|
US |
Wall St Price Targets
XCY Price Targets Summary
OPKO Health Inc
According to Wall Street analysts, the average 1-year price target for XCY is 3.8 EUR with a low forecast of 2.58 EUR and a high forecast of 7.59 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XCY's stock price target?
Price Target
3.8
EUR
According to Wall Street analysts, the average 1-year price target for XCY is 3.8 EUR with a low forecast of 2.58 EUR and a high forecast of 7.59 EUR.
What is the Revenue forecast for OPKO Health Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for OPKO Health Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 5 years is 6%.
